Comprehensive Lab Testing
Biomarker tracking with 28+ metabolic health markers
Service · HybridCompany source
Company profile
About Levels
Levels combines continuous glucose monitoring with AI-powered insights to help users understand how food, exercise, and lifestyle affect metabolic health.
Company description Levels official website
Primary marketMetabolic Health & Nutrition
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Levels?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- glucose control
- heart health
- insulin resistance
- metabolic health
- prediabetes
- weight loss
Who it serves
- consumers
- practitioners
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: Apple Health, Dexcom CGM, Google Fit.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
100,000+ lives changed, launched comprehensive research study with 10,000+ participants, expanded product offerings to include three tiers (Build, Core, Complete)
Partnerships
Recorded partners
- Dexcom
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Continuous Glucose Monitoring (CGM) Integration
Real-time glucose tracking integrated with lifestyle data
Platform · HybridCompany source
Guided Programs
Structured programs for glucose control, heart health, and weight loss
Service · Cloud SaaSCompany source
Levels App
Metabolic health system that helps you see how food affects your body
Software · Cloud SaaSCompany source
LevelsAI
AI-powered metabolic health assistant
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.GeroScience · Aug 10, 2026
Sustainability accounting and reporting adoption across Italian public healthcare system: What role of the institutional pressures?Health services management research · Jun 30, 2026
Knowledge, Skills, and Attitudes of Nursing Students Toward Artificial Intelligence: A Scoping Review.Computers, informatics, nursing : CIN · Jun 1, 2026
Poetry Online Engagement Among Military-Connected Individuals and Impact on Suicidality.Military medicine · May 8, 2026
A retrospective cross-sectional study comparing health-related quality-of-life in females with lipoedema and bilateral leg lymphoedema.Journal of psychosomatic research · Apr 1, 2026
Warmth When It Matters Most: Addressing the Overnight Needs of Homeless Emergency Room Patients.Healthcare quarterly (Toronto, Ont.) · Jan 1, 2026
Clinical validation
Clinical-trial records
Understanding the Paradoxical Rise in Blood Glucose in the Context of a Low-carbohydrate DietNCT07713316 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
81% improved HbA1c
Among members who started in the prediabetes range
79% improved fasting insulin
Members with insulin resistance
84% improved triglycerides
Members who started high
40%+ reduction in ApoB
Member testimonial without medication
Julie Smith
Life-changing metabolic health intervention
Member reported 'it probably saved my life'
Levels Member Cohort - HbA1c
Prediabetes reversal through sustained behavior change
81% of members who started in prediabetes range improved their HbA1c level
Levels Member Cohort - Insulin
Insulin resistance improvement through metabolic monitoring
79% of members with insulin resistance saw meaningful improvement
Levels Member Cohort - Triglycerides
Cardiovascular risk reduction through lifestyle changes
84% of members who started with high triglycerides saw significant reduction
Mike Didonato
Cardiovascular health improvement through metabolic monitoring
Reduced ApoB by more than 40% without medication
Tony Hedges
Weight loss through metabolic tracking
Lost significant weight with 15 more pounds to target goal
Traci Lowe
Weight management and metabolic health improvement
Weight reduced from 153 to 127 pounds
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Levels
Recent articles published on Levels's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
How Tomorrow's Weather Could Predict Your Hospital's Mental Health Crisis Load
A decade-long analysis of 15 million NHS contacts reveals that daily weather fluctuations—from temperature swings to rainfall—significantly influence mental health service demand, opening new frontiers for AI-powered healthcare forecasting.
Mental & Behavioral Health · Jul 3, 2026
RNA-Targeting Breakthrough: Ionis Scores Dual Wins with First-Ever FCS Therapy and $430M Licensing Deal
FDA approval of Tryngolza for ultra-rare pancreatitis disorder and major partnership for hereditary angioedema treatment signal growing confidence in antisense oligonucleotide technology.
Drug Discovery & Research · Jul 3, 2026
Georgia Hospital Tackles Paramedic PTSD with Peer Counselors and a Four-Legged Therapist
By pairing peer counselors with therapy dogs, one Georgia health system is breaking the stigma around mental health in emergency medical services.
Mental & Behavioral Health · Jun 26, 2026
Why Your Hospital's AI Dreams May Be Failing Before They Start: The Infrastructure Gap No One Talks About
Most hospital AI projects fail not because the technology is flawed, but because foundational data infrastructure wasn't built first.
AI Infrastructure · Jun 26, 2026
Healthcare's AI Darwinism: Why Most Hospitals Will Fail the Autonomous Revolution
Healthcare organizations face mounting pressure to adopt autonomous AI systems or risk competitive obsolescence in what industry observers describe as a technological survival test.
Clinical AI · Jun 16, 2026
Dexcom Stelo OTC Continuous Glucose Monitor Reaches One Million Users
Dexcom has announced that its Stelo continuous glucose monitor — the first OTC CGM approved by the FDA — has reached one million users, with the majority being people without diabetes who are using the device for metabolic health optimization.
Digital Health & Wearables · Apr 18, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Metabolic Health & Nutrition
Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.